Literature DB >> 7173520

Glucose inhibits replication of cultured human endothelial cells.

R W Stout.   

Abstract

Diabetes is an important risk factor for atherosclerosis but the mechanism of the risk is unknown. As endothelial injury is considered to be an early event in the development of atherosclerosis, the effect of glucose on endothelial cell replication was studied. Concentrations of glucose of 11.2, 16.8 and 22.4 mmol/l inhibited DNA synthesis in cultured human umbilical venous endothelial cells by 8.1 +/- 10.8, 24.3 +/- 8.8 and 30.9 +/- 7.4%, respectively. Glucose also inhibited the proliferative response of endothelial cells to experimental wounds in the cell layer. Sorbitol (22.4 mmol/l) inhibited endothelial cell DNA synthesis by 50 +/- 13.6%, but mannitol (22.4 mmol/l) inhibited DNA synthesis by only 3 +/- 24.3%. It is suggested that in diabetic subjects, high blood glucose levels may cause endothelial injury, or inhibit its repair, and hence allow the exposure of the arterial media to plasma and its constituents.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7173520     DOI: 10.1007/bf00260958

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  20 in total

Review 1.  The pathogenesis of atherosclerosis (first of two parts).

Authors:  R Ross; J A Glomset
Journal:  N Engl J Med       Date:  1976-08-12       Impact factor: 91.245

2.  George Lyman Duff Memorial Lecture. Atherosclerosis: a problem of the biology of arterial wall cells and their interactions with blood components.

Authors:  R Ross
Journal:  Arteriosclerosis       Date:  1981 Sep-Oct

3.  Effects of glucose and sorbitol on proliferation of cultured human skin fibroblasts and arterial smooth-muscle cells.

Authors:  J L Turner; E L Bierman
Journal:  Diabetes       Date:  1978-05       Impact factor: 9.461

4.  Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria.

Authors:  E A Jaffe; R L Nachman; C G Becker; C R Minick
Journal:  J Clin Invest       Date:  1973-11       Impact factor: 14.808

5.  Diabetes and cardiovascular risk factors: the Framingham study.

Authors:  W B Kannel; D L McGee
Journal:  Circulation       Date:  1979-01       Impact factor: 29.690

6.  Effect of insulin on growth of cultured human arterial smooth muscle cells.

Authors:  B Pfeifle; H Ditschuneit
Journal:  Diabetologia       Date:  1981-02       Impact factor: 10.122

7.  Control of DNA synthesis in cultured vascular endothelial and smooth muscle cells--response to serum, platelet-deficient serum, lipid-free serum, insulin and oestrogens.

Authors:  H Taggart; R W Stout
Journal:  Atherosclerosis       Date:  1980-12       Impact factor: 5.162

8.  Coronary heart disease incidence and cardiovascular mortality in Busselton with reference to glucose and insulin concentrations.

Authors:  T A Welborn; K Wearne
Journal:  Diabetes Care       Date:  1979 Mar-Apr       Impact factor: 19.112

9.  Coronary-heart-disease risk and impaired glucose tolerance. The Whitehall study.

Authors:  J H Fuller; M J Shipley; G Rose; R J Jarrett; H Keen
Journal:  Lancet       Date:  1980-06-28       Impact factor: 79.321

10.  Human vascular endothelial cells in culture. Growth and DNA synthesis.

Authors:  M A Gimbrone; R S Cotran; J Folkman
Journal:  J Cell Biol       Date:  1974-03       Impact factor: 10.539

View more
  11 in total

1.  Effect of elevated glucose concentrations on cellular lipid peroxidation and growth of cultured human kidney proximal tubule cells.

Authors:  S K Jain; K M Morshed; K Kannan; K E McMartin; J A Bocchini
Journal:  Mol Cell Biochem       Date:  1996-09-06       Impact factor: 3.396

Review 2.  Endothelial cell function in diabetic microangiopathy.

Authors:  M Porta; M La Selva; P Molinatti; G M Molinatti
Journal:  Diabetologia       Date:  1987-08       Impact factor: 10.122

3.  Differential modulation of mitogenic and metabolic actions of insulin-like growth factor I in rat glomerular mesangial cells in high glucose culture.

Authors:  R Kikkawa; M Haneda; M Togawa; D Koya; N Kajiwara; Y Shigeta
Journal:  Diabetologia       Date:  1993-04       Impact factor: 10.122

4.  High glucose concentrations do not influence replication and prostacyclin release of human endothelial cells.

Authors:  B J Weimann; E Lorch; H R Baumgartner
Journal:  Diabetologia       Date:  1984-07       Impact factor: 10.122

5.  Effect of an aldose reductase inhibitor on type IV collagen production by human endothelial cells cultured in high glucose.

Authors:  A Bakillah; A M Grigorova-Borsos; R Guillot; P Urios; M Sternberg
Journal:  Diabetologia       Date:  1996-06       Impact factor: 10.122

6.  Continued platelet interaction with de-endothelialized aortae associated with slower re-endothelialization and more extensive intimal hyperplasia in spontaneously diabetic BB Wistar rats.

Authors:  P D Winocour; M Richardson; R L Kinlough-Rathbone
Journal:  Int J Exp Pathol       Date:  1993-12       Impact factor: 1.925

Review 7.  The role of endothelium in the pathogenesis of diabetic microangiopathy.

Authors:  M La Selva; E Beltramo; P Passera; M Porta; G M Molinatti
Journal:  Acta Diabetol       Date:  1993       Impact factor: 4.280

8.  Sera from type 2 (non-insulin-dependent) diabetic and healthy subjects contain different amounts of a very low molecular weight growth peptide for vascular cells.

Authors:  T Koschinsky; C E Bünting; R Rütter; F A Gries
Journal:  Diabetologia       Date:  1985-04       Impact factor: 10.122

9.  Increased aortic endothelial death and enhanced transendothelial macromolecular transport in streptozotocin-diabetic rats.

Authors:  S J Lin; C Y Hong; M S Chang; B N Chiang; S Chien
Journal:  Diabetologia       Date:  1993-10       Impact factor: 10.122

10.  Haemostatic variables, serum lipid abnormalities and vascular complications in diabetes mellitus: a 5 year follow-up study.

Authors:  G Gamba; S B Solerte; G Grignani; L Pacchiarini; N Montani; E Ferrari
Journal:  Blut       Date:  1988-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.